Gland Pharma Limited has informed the Exchange regarding 'Intimation of ESOP Compensation Committee Meeting'.
GLAND · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Gland Pharma has informed exchanges that a meeting of its ESOP Compensation Committee is scheduled for May 15, 2026. The agenda includes considering and approving the grant of stock options under the company's Employee Stock Option Scheme 2025 (ESOP 2025). This is a routine pre-meeting disclosure filed on May 12, 2026, by the Company Secretary. No details on the number of options, eligible employees, or pricing have been disclosed at this stage.
This is a standard regulatory intimation and carries no immediate impact on the stock. The actual grant details, once approved, may have a minor dilutive effect and signal management confidence in the company's future performance.